Skip to main content
logo
Sarepta Therapeutics, Inc. (SRPT)
NASDAQ: SRPT · Real-Time Price · USD
15.68
-0.20 (-1.26%)
At close: Jul 24, 2026, 4:00 PM EDT
15.88
+0.20 (1.28%)
Pre-market: Jul 27, 2026, 4:01 AM EDT

Sarepta Therapeutics Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
2,1842,1981,9021,243933.01701.89
Revenue Growth
-2.20%15.58%52.97%33.26%32.93%29.95%
Gross Profit
1,3731,3591,5831,093793.02604.84
Operating Income
-40.96-699.78218.08-267.82-536.2-459.71
Net Income
65.06-713.41235.24-535.98-703.49-418.78
Earnings Per Share
-0.96-7.132.34-5.80-8.03-5.15
EPS Growth
------

Revenue by Segment
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total PMO Products
957.58965.57967.17944.52843.77612.4
ELEVIDYS
625.71898.73820.79200.36--
Collaboration and Other
600.9333.94114.0298.4689.2489.49
Revenue (Total)
2,1842,1981,9021,243933.01701.89

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
653.19939.651,3551,6761,9892,116
Total Debt
1,0371,0281,3301,3791,6171,138
Net Cash (Debt)
-383.48-88.725.2297.29372.02977.48
Net Cash Growth
---91.53%-20.09%-61.94%12.91%
Net Cash Per Share
-3.54-0.890.233.224.2512.03

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-311.89-205.48-205.79-500.99-325.35-443.17
Capital Expenditures
-60.4-101.97-136.96-76.11-30.82-38.49
Free Cash Flow
-372.29-307.45-342.74-577.1-356.17-481.66
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
62.88%61.81%83.22%87.91%85.00%86.17%
Operating Margin
-1.88%-31.83%11.47%-21.54%-57.47%-65.50%
Pretax Margin
1.12%-31.94%13.71%-41.83%-73.95%-59.69%
Profit Margin
2.98%-32.45%12.37%-43.11%-75.40%-59.66%
FCF Margin
-17.04%-13.99%-18.02%-46.42%-38.17%-68.62%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
24.59-51.96---
Forward PE
20.0190.1215.47---
PS Ratio
0.761.036.197.2712.2111.18